Robert A. Pospisil

Analysis of the largest antihypertensive trial ever offers useful blueprint for sites in boosting subject enrollment.

Data on the relationship between investigator characteristics and cardiovascular clinical trial patient recruitment are extremely limited in scientific literature. An analysis of ALLHAT, the largest antihypertensive clinical study ever conducted, identifies key investigator and site characteristics that can strengthen subject enrollment.